Phillip Moore, MD
Vascular Surgery · Winston Salem, NCNPI 1215119151
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,616 of the $3,549 with a category attached, or 73.7%. 23 manufacturers reported payments, led by Globus Medical at 27.9% of the total. Reporting peaked in 2019 at $1,891 and has fallen 92.5% since, to $143 in 2025.
Across 56 payments — averaging $63.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$989
- W. L. Gore & Associates, Inc.$524
- Silk Road Medical, Inc.$467
- Penumbra, Inc.$361
- Cook Medical LLC$171
- Medtronic$164
- plus $874 from 17 others
Across 13 payments — averaging $8013.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- W. L. Gore & Associates, Inc.$104K
What the payments were for
- Travel & lodging$91726%
- Food & beverage$2,61674%
- Entertainment$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 5 | $989 |
| W. L. Gore & Associates, Inc. | 6 | $524 |
| Silk Road Medical, Inc. | 6 | $467 |
| Penumbra, Inc. | 4 | $361 |
| Cook Medical LLC | 3 | $171 |
| Medtronic(2 entities) | 7 | $164 |
| Shockwave Medical, Inc | 2 | $148 |
| Cvrx, Inc. | 1 | $127 |
| Getinge USA Sales, LLC | 1 | $124 |
| Boston Scientific | 3 | $81 |
| Bard Peripheral Vascular, Inc. | 1 | $73 |
| Inari Medical, Inc. | 3 | $68 |
| Sanara Medtech Inc. | 2 | $42 |
| Amgen | 2 | $40 |
| Haemonetics Corporation | 1 | $37 |
| Angiodynamics, Inc. | 2 | $32 |
| Abbott | 1 | $25 |
| Tactile Systems Technology Inc | 1 | $18 |
| Novo Nordisk | 1 | $16 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Surmodics, Inc. | 1 | $7 |
| Lemaitre Vascular, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XLIF$844
- ALIF$844
- EXCLUDER AAA Endoprosthesis$435
- ENROUTE Transcarotid Neuroprotection System$407
- ENROUTE Transcarotid Stent$407
- Penumbra System$318
- Indigo$170
- ENROUTE .014 Guidewire$138
- ENHANCE Transcarotid Peripheral Access Kit$138
- Cook$136
- Barostim Neo System$127
- iCAST$124
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$123
How this compares
$3,549 in reported general payments places this provider in the 55th percentile of 119 vascular surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 89 | $66,760 |
| XareltoRivaroxaban | 36 | $33,825 |
| ClopidogrelClopidogrel Bisulfate | 169 | $1,344 |
| Atorvastatin Calcium | 41 | $538 |
| Pravastatin Sodium | 28 | $483 |
| Amlodipine Besylate | 13 | $273 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $112 |
| Oxycodone Hcl | 17 | $109 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $15 | $33,82536 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 119 vascular surgery providers in North Carolina.
Other vascular surgery in Winston Salem
- Suman WasanWinston Salem$72K
- Gabriela Velazquez RamirezWinston Salem$34K
- Matthew GoldmanWinston Salem$11K
- Lindsay LynchWinston Salem$9K
- Justin HurieWinston Salem$6K
- Shawn FlemingWinston Salem$3K
- Frank ArkoCharlotte$2.6M
- Erin MurphyCharlotte$598K
- Robert MendesRaleigh$408K
- Ellen DillavouRaleigh$284K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.